Trends News Trends In Small Cell Lung Cancer Incidence And Survival
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Trends News Trends In Small Cell Lung Cancer Incidence And Survival is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
How AI helps detect lung cancer sooner, improving survival rates
New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the chances of patients’ survival. Read More
A Look at the Past, Present, and Future of Small Cell Lung Cancer Treatment
Future SCLC treatment may involve combining T-cell engagers with immune checkpoint inhibitors to enhance patient outcomes. The landscape of small cell lung cancer (SCLC) is undergoing a significant ... Read More
Imdelltra May Improve Survival in Small Cell Lung Cancer
Imdelltra significantly improves survival in SCLC patients post-platinum chemotherapy, meeting primary endpoints in the DeLLphi-304 trial. As a BiTE immunotherapy, Imdelltra enhances T cell-cancer ... Read More
Imdelltra Shows Survival Benefit in Small Cell Lung Cancer
Imdelltra significantly improved progression-free and overall survival compared to chemotherapy in small cell lung cancer patients, with a median overall survival of 13.6 months versus 8.3 months. The ... Read More
Tarlatamab Improves Overall Survival in Small Cell Lung Cancer
Results showed tarlatamab demonstrated statistically significant and clinically meaningful improvement in overall survival vs standard of care therapy. Topline data were announced from a phase 3 trial ... Read More
FDA Grants Full Approval To Amgen's Imdelltra In Extensive Stage Small Cell Lung Cancer
Global Confirmatory Phase 3 DeLLphi-304 Trial Showed IMDELLTRA Reduced Risk of Death by 40% Compared to Chemotherapy Underscores IMDELLTRA as a Recognized Standard ... Read More
Lung Cancer Survival Has Improved in US, American Lung Association Report Shows
In just the past 8 years since we launched this report, the 5-year survival rate has gone from 18% to nearly 30%,” said Harold Wimmer, President and CEO of the American Lung Association. In the US, ... Read More
Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in Patients with EGFR-Mutant Non-Small ...
MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced topline results from the Phase III clinical trial, HARMONi, the first global Phase ... Read More
Defying the Odds With Small Cell Lung Cancer: Montessa Lee’s 19-Year Journey Is a Beacon of Hope
Diagnosed with small-cell lung cancer at 28, Montessa Lee has defied the odds for nearly 20 years, surviving a disease with a historically low survival rate of just 5–10% according to the National ... Read More
Characteristics and Associated Survival of Patients Diagnosed With Non–Small Cell Lung Cancer in a Designated Lung Cancer Program in Western Kenya
Two hundred forty-nine patients diagnosed with NSCLC were included with a median age at diagnosis of 61 (IQR, 52-70) years. Most patients were married (n = 177; 71%) and nonsmokers (n = 177; 71%) with ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus